Home ETF List About

ETF Holdings Breakdown of VRTX

Stock NameVertex Pharmaceuticals Inc
TickerVRTX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92532F1003
LEI54930015RAQRRZ5ZGJ91

VRTX institutional holdings

The following institutional investment holdings of VRTX have been identified

Date ETF ISIN/Name Num Shares Book value
2025-10-23 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 609,864 0.0%USD 257,746,822 -0.9%
2025-10-23 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 609,864USD 257,746,822
2025-10-23 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 609,864 0.0%USD 257,746,822 -0.9%
2025-10-23 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 390,392USD 164,991,371 -0.9%
2025-10-23 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 390,392USD 164,991,371 -0.9%
2025-10-23 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 390,392USD 164,991,371
2025-10-23 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 390,392USD 164,991,371 -0.9%
2025-10-22 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 75,446 2.5%USD 32,173,192 2.5%
2025-10-22 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 90,729 0.0%USD 38,690,475 0.0%
2025-10-23 IE00B53SZB19 (iShares NASDAQ 100 UCITS ETF USD (Acc)) 318,137USD 134,454,240
2025-10-23 IE00BYVQ9F29 (iShares NASDAQ 100 UCITS ETF) 318,137USD 134,454,240
2025-10-23 IE00BYX2JD69 (iShares MSCI World SRI UCITS ETF) 136,112USD 57,525,015
2025-10-23 IE00BMZ17T93 (iShares MSCI World SRI UCITS ETF GBP Hedged (Dist) GBP) 136,112USD 57,525,015
2025-10-23 IE00BMZ17X30 (iShares MSCI World SRI UCITS ETF USD Hedged (Dist)) 136,112USD 57,525,015
2025-10-23 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 79,712USD 33,688,683
2025-10-23 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 79,712USD 33,688,683
2025-10-23 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 79,712USD 33,688,683 -0.9%
2025-10-23 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 221,587 200.0%USD 93,649,314 200.9%
2025-10-23 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 221,587 200.0%USD 93,649,314 200.9%
2025-10-23 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 27,341USD 11,555,127
2025-10-23 IE00BYVJRR92 (iShares MSCI USA SRI UCITS ETF USD (Acc)) 73,827USD 31,201,505
2025-10-23 IE00BZ173V67 (iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)) 73,827USD 31,201,505
2025-10-23 IE00BZ173T46 (iShares MSCI USA SRI UCITS ETF USD (Dist)) 73,827 -0.1%USD 31,201,505 -1.0%
2025-10-23 IE00BMWPV470 (iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist)) 73,827 -0.1%USD 31,201,505 -1.0%
2025-10-23 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 40,989USD 14,915,775
2025-10-23 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 22,093USD 9,337,165
2025-10-23 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 22,093USD 9,337,165 -0.9%
2025-10-23 IE00BP3QZ601 (iShares Edge MSCI World Quality Factor UCITS ETF) 23,751USD 10,037,885
2025-10-23 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 19,542 0.4%USD 8,259,035 1.3%
2025-10-23 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 19,542USD 8,259,035
2025-10-23 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 21,399 -0.1%USD 9,043,859 -1.0%
2025-10-23 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 21,399 -0.1%USD 9,043,859 -1.0%
2025-10-23 IE00B8FHGS14 (iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc)) 32,552USD 13,757,452
2025-10-23 IE00BGPP8L80 (iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)) 32,552USD 13,757,452 -0.9%
2025-10-23 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 16,921USD 6,157,501
2025-10-23 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 126,569USD 53,491,856
2025-10-23 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 126,569USD 53,491,856 -0.9%
2025-10-23 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 11,398USD 4,817,137
2025-10-23 IE00B6SPMN59 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc)) 27,698USD 11,706,006
2025-10-23 IE00BD93YH54 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist)) 27,698USD 11,706,006
2025-10-22 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 5,189USD 2,212,797 0.0%
2025-10-23 IE0002W8NB38 (iShares MSCI USA Swap UCITS ETF USD (Acc)) 22,832USD 9,649,488
2025-10-23 IE00BKVL7778 (iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)) 15,406USD 6,511,038
2025-10-23 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 33,257USD 14,055,406
2025-10-23 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 33,257USD 14,055,406
2025-10-23 IE00BMXC7V63 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc)) 1,330 -1.2%USD 562,098 -2.1%
2025-10-23 IE000G4PH2B1 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist) 1,330USD 562,098
2025-10-23 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 6,204USD 1,968,096 -0.7%
2025-10-23 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 1,504USD 635,636
2025-10-23 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 1,504USD 635,636
2025-10-23 IE00BKVL7331 (iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc)) 5,691USD 2,405,187 -0.9%
2025-10-23 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 1,720USD 545,636
2025-10-23 IE000NITTFF2 (iShares Russell 1000 Growth UCITS ETF) 3,996USD 1,688,829 -0.9%
2025-10-23 IE00013A2XD6 (iShares MSCI ACWI SRI UCITS ETF USD(Dist)) 1,455USD 614,927
2025-10-23 IE000KJPDY61 (iShares World Equity High Income UCITS ETF USD Inc) 502USD 212,160
2025-10-23 IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc)) 2,088USD 882,451
2025-10-23 IE0009VWHAE6 (iShares US Equity Enhanced Active UCITS ETF USD (Acc)) 1,268USD 535,895
2025-10-23 IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist)) 42USD 17,750
2025-10-23 IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc)) 42USD 17,750
2025-10-23 IE0007O06KL9 (iShares Russell 2000 Swap UCITS ETF) 1,827USD 772,145
2025-10-23 IE000YG82CF0 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Dist)) 37USD 15,637
2025-10-23 IE000MGAVJV3 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Acc)) 37USD 15,637
2025-10-23 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 133,336USD 56,351,794
2025-10-23 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 133,336USD 56,351,794
2025-10-22 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 69,662USD 29,706,663 0.0%
2025-10-23 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 69,662USD 29,441,251
Total =6,746,183 USD 2,847,821,215
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with VRTX

Vertex Pharmaceuticals Secures Italian Reimbursement Agreement For Gene-Edited Therapy CASGEVY
(RTTNews) - Vertex Pharmaceuticals (VRTX), Thursday announced a reimbursement agreement with the Italian Medicines Agency that allows eligible transfusion-dependent beta thalassemia and severe sickle cell disease patients to access the CRISPR/Cas9 gene-edited therapy CASGEVY. - 2025-09-18 14:26:15
Noteworthy ETF Inflows: CGBL, CGCP, CGCB, VRTX
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Core Balanced ETF (Symbol: CGBL) where we have detected an approximate $272.2 million dollar inflow -- that's a 9.7% increase week over - 2025-08-15 11:50:39
Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Strong-Buy at Wall Street Zen
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a report issued on Saturday. A number of other research firms have also recently weighed in on VRTX. Wells Fargo & Company raised shares of Vertex Pharmaceuticals from an “equal […] - 2025-08-11 02:58:48
Harbour Investments Inc. Acquires 68 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Harbour Investments Inc. increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 19.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 410 shares of the pharmaceutical company’s stock after purchasing an additional 68 shares during the period. Harbour […] - 2025-08-07 05:54:57
Vertex Pharmaceuticals (NASDAQ:VRTX) Reaches New 52-Week Low on Analyst Downgrade
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. Canaccord Genuity Group currently has a hold rating on the stock. Vertex Pharmaceuticals traded as low as $373.19 and last traded […] - 2025-08-07 05:08:45
Scotiabank Issues Pessimistic Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target lowered by Scotiabank from $442.00 to $438.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “sector perform” rating on the pharmaceutical company’s stock. Scotiabank’s target price suggests a potential upside of 13.57% from the company’s current price. Other research analysts […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $490.00 by Truist Financial
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) received a $490.00 price objective from Truist Financial in a report issued on Tuesday, MarketBeat reports. The firm presently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price objective indicates a potential upside of 27.06% from the company’s previous close. A number of other equities […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) Shares Gap Down Following Analyst Downgrade
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) shares gapped down before the market opened on Tuesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. The stock had previously closed at $472.27, but opened at $408.22. Canaccord Genuity Group currently has a hold rating on the stock. Vertex […] - 2025-08-07 02:42:43
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $455.00 by Analysts at Stifel Nicolaus
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective reduced by Stifel Nicolaus from $494.00 to $455.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the pharmaceutical company’s stock. VRTX has been the topic of several other reports. Scotiabank dropped their target price […] - 2025-08-06 04:40:55
Royal Bank Of Canada Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $405.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective trimmed by Royal Bank Of Canada from $430.00 to $405.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmaceutical company’s stock. A number of other equities research analysts have also issued reports […] - 2025-08-06 04:40:55
HC Wainwright Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price decreased by HC Wainwright from $550.00 to $478.00 in a research report released on Tuesday,Benzinga reports. HC Wainwright currently has a buy rating on the pharmaceutical company’s stock. A number of other equities research analysts have also recently weighed in on VRTX. Leerink Partnrs cut […] - 2025-08-06 04:40:51
Nasdaq 100 Movers: VRTX, AXON
In early trading on Tuesday, shares of Axon Enterprise topped the list of the day's best performing components of the Nasdaq 100 index, trading up 13.3%. Year to date, Axon Enterprise registers a 42.0% gain. And the worst performing Nasdaq 100 component thus far on the day is - 2025-08-05 11:25:39
Selloff? What Selloff? Monday Market Rebound
Palantir is way up after reporting Q2 results Monday afternoon, while HIMS and VRTX are way off highs. - 2025-08-04 19:18:00
After-Hours Earnings Report for August 4, 2025 : PLTR, MELI, VRTX, WMB, AXON, SPG, OKE, FANG, SBAC, EQR, CRBG, CTRA
The following companies are expected to report earnings after hours on 08/04/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Palantir Technologies Inc. (PLTR)is reporting for the quarter ending June 30, 2025. The internet software company's consen - 2025-08-04 15:00:01
Choreo LLC Buys 301 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Choreo LLC raised its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 4.9% during the 1st quarter, Holdings Channel.com reports. The fund owned 6,393 shares of the pharmaceutical company’s stock after purchasing an additional 301 shares during the quarter. Choreo LLC’s holdings in Vertex Pharmaceuticals were worth $3,099,000 as of its […] - 2025-07-24 06:51:01
607 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Acquired by Ignite Planners LLC
Ignite Planners LLC bought a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 607 shares of the pharmaceutical company’s stock, valued at approximately $303,000. Other large investors have also bought and sold shares of […] - 2025-07-24 05:51:10
Private Advisor Group LLC Raises Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Private Advisor Group LLC raised its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 3.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,452 shares of the pharmaceutical company’s stock after purchasing an additional 242 shares […] - 2025-07-23 06:25:05
TQQQ, VRTX, MELI, CTAS: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro QQQ (Symbol: TQQQ) where we have detected an approximate $303.8 million dollar outflow -- that's a 1.1% decrease week over week ( - 2025-07-22 12:10:43
Edgestream Partners L.P. Has $358,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Edgestream Partners L.P. trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 87.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 738 shares of the pharmaceutical company’s stock after selling 5,104 shares during the quarter. Edgestream Partners L.P.’s […] - 2025-07-21 04:56:54
Brown Advisory Inc. Grows Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Brown Advisory Inc. grew its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 12.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 6,581 shares of the pharmaceutical company’s stock after purchasing an additional 739 shares during the quarter. Brown Advisory Inc.’s holdings in Vertex Pharmaceuticals were worth $3,191,000 as […] - 2025-07-13 06:44:54
Penserra Capital Management LLC Reduces Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Penserra Capital Management LLC lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 81.3% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 126 shares of the pharmaceutical company’s stock after selling 548 shares during the period. Penserra Capital […] - 2025-07-13 05:34:49
Diversified Trust Co Boosts Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Diversified Trust Co lifted its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 17.7% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 632 shares of the pharmaceutical company’s stock after purchasing an additional 95 shares during the quarter. Diversified Trust Co’s […] - 2025-07-02 05:23:01
Notable ETF Inflow Detected - JEPQ, CMCSA, VRTX, MELI
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the JPMorgan Nasdaq Equity Premium Income ETF (Symbol: JEPQ) where we have detected an approximate $191.3 million dollar inflow -- that's a 0.7% increase - 2025-06-30 11:59:10
Blue Trust Inc. Sells 61 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Blue Trust Inc. trimmed its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 9.6% in the 1st quarter, Holdings Channel reports. The fund owned 573 shares of the pharmaceutical company’s stock after selling 61 shares during the quarter. Blue Trust Inc.’s holdings in Vertex Pharmaceuticals were worth $278,000 as of its most recent […] - 2025-06-23 05:00:57
Trust Point Inc. Sells 738 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Trust Point Inc. lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 62.8% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 437 shares of the pharmaceutical company’s stock after selling 738 shares during the period. Trust Point Inc.’s holdings in Vertex Pharmaceuticals were worth $212,000 as of […] - 2025-06-19 05:35:07
Exchange Traded Concepts LLC Sells 322 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Exchange Traded Concepts LLC reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 10.9% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,623 shares of the pharmaceutical company’s stock after selling 322 shares during the period. Exchange Traded Concepts […] - 2025-06-19 04:57:08
Royal Bank Of Canada Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $420.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target dropped by Royal Bank Of Canada from $423.00 to $420.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “sector perform” rating on the pharmaceutical company’s stock. Royal Bank Of Canada’s price objective points to a potential downside of 6.33% […] - 2025-06-19 02:18:56
514 Shares in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Purchased by OLD National Bancorp IN
OLD National Bancorp IN purchased a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 514 shares of the pharmaceutical company’s stock, valued at approximately $249,000. Several other […] - 2025-06-11 06:08:50
Noteworthy ETF Inflows: MGK, NOW, UBER, VRTX
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Mega Cap Growth ETF (Symbol: MGK) where we have detected an approximate $412.8 million dollar inflow -- that's a 1.6% increase week over wee - 2025-06-05 12:15:02
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Short Interest Update
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 4,820,000 shares, an increase of 27.5% from the April 30th total of 3,780,000 shares. Approximately 1.9% of the company’s shares are sold short. […] - 2025-06-05 02:38:59

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.